Skip to main content
Assertio Holdings, Inc. (ASRT)
NASDAQ: ASRT · Real-Time Price · USD
11.66
-0.31 (-2.59%)
At close: Feb 27, 2026, 4:00 PM EST
11.72
+0.06 (0.48%)
After-hours: Feb 27, 2026, 6:06 PM EST

Assertio Holdings Revenue

Assertio Holdings had revenue of $49.46M in the quarter ending September 30, 2025, with 69.36% growth. This brings the company's revenue in the last twelve months to $137.35M, up 9.22% year-over-year. In the year 2024, Assertio Holdings had annual revenue of $124.96M, down -17.83%.

Revenue (ttm)
$137.35M
Revenue Growth
+9.22%
P/S Ratio
0.55
Revenue / Employee
$2,368,172
Employees
58
Market Cap
75.14M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024124.96M-27.11M-17.83%
Dec 31, 2023152.07M-4.17M-2.67%
Dec 31, 2022156.23M45.22M40.73%
Dec 31, 2021111.01M2.94M2.72%
Dec 31, 2020108.08M-121.45M-52.91%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Anika Therapeutics 112.81M
Rockwell Medical 75.58M
InterCure 72.16M
Cumberland Pharmaceuticals 41.28M
Alpha Teknova 39.80M
Zhengye Biotechnology Holding 21.46M
BioXcel Therapeutics 752.00K
Talphera 28.00K
Revenue Rankings

ASRT News

More News